ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Antibiotic Pretreatment Alleviates Liver Transplant Damage by Modulating the Composition of Commensal Microbiota

K. J. Dery, S. Kageyama, H. Hirao, K. Kadono, H. Kojima, R. W. Busuttil, J. W. Kupiec-Weglinski

Surgery, Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA

Meeting: 2020 American Transplant Congress

Abstract number: A-328

Keywords: Bacterial infection, Gene expression, Graft failure, Liver

Session Information

Session Name: Poster Session A: Biomarker Discovery and Immune Modulation

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: The human intestinal microbiome contains more than 100 trillion commensal microorganisms, exceeding the number of cells in the human body by 10-fold. Although recent evidence shows that modifications of gut microbiota by antibiotics (Abx) may influence liver allograft function in mice and humans, its compositional role in orthotopic liver transplantation (OLT) remains unknown. Here, we aimed to determine whether and how the recipient commensal microbiota composition may affect hepatic ischemia-reperfusion injury (IRI) and OLT outcomes.

*Methods: Balb/c livers subjected to cold storage (18 h) were transplanted to C57/BL6 mouse recipients, which were treated with/without amoxicillin (50mg/ml x10 days/drinking water) in the following groups: 1/Sham-treated (n=4), 2/Recipient Abx (n=6), 3/Abx+ Fecal Microbiota Transplantation (FMT; n=6), and 4/OLT (n=3). For FMT experiments, stool collected from naive untreated C57BL/6 mice was administered to amoxicillin-fed C57BL/6 mice (days -11 to -1). These were conditioned with/without FMT (200 mg/ml by gavage) on day -1 and 0 prior to OLT. Genomic DNA of fecal samples were isolated (day +1) and subjected to microbiome 16S rRNA gene sequencing.

*Results: Taxonomic classification using principal component analysis revealed significant differences between the Abx-treated and untreated groups in the family-, genus, and species-level analyses. Faith’s Phylogenetic Diversity index, Shannon Index, and Chao1 Index all revealed significant declines in taxon richness, species diversity, and overall abundance after Abx-treatment alone. By contrast, FMT re-established the microbiota to Sham and OLT-levels, suggesting that our normal commensal flora is antagonistic to liver IRI-resistance. The bacterial phyla Verrucomicrobia and Firmicutes showed the largest decline of representation in the Abx-treated microbiota as compared to Sham-treated controls. At the genus level, Akkermansia muciniphila and Bacteroides thetaiotaomicron were among the most abundant while Clostridium sensu stricto and Romboutsia were the least abundant bacteria in the Abx-pretreatment mice characterized with well-preserved post-OLT hepatocellular function.

*Conclusions: This novel study identifies how Abx recipient pretreatment fundamentally alters the microbiome composition pre- and post-OLT. Selective compositional changes rather than overall bacteria levels are indicative of OLT resistance against IR-stress. Hence, Bacteroides, Akkermansia, and Turicibacter are identified as putative cytoprotective microbes; while Firmicutes, Clostridium and Ruminococcaceae are candidates that play a cytotoxic role in OLT recipients.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Dery KJ, Kageyama S, Hirao H, Kadono K, Kojima H, Busuttil RW, Kupiec-Weglinski JW. Antibiotic Pretreatment Alleviates Liver Transplant Damage by Modulating the Composition of Commensal Microbiota [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/antibiotic-pretreatment-alleviates-liver-transplant-damage-by-modulating-the-composition-of-commensal-microbiota/. Accessed May 16, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences